JNJ News and Press, Johnson & Johnson From 03/04/26

2026-03-04 19:42:29 ET It has been an interesting start to 2026. There has been back-and-forth on tariffs that have introduced volatility. We have seen an AI-disruption fear sweep the market and knock several sectors back that could, in theory, be displaced by AI, adding volatility. We ...

2026-03-04 10:51:59 ET More on Bayer Bayer Aktiengesellschaft 2025 Q4 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation Transcript Bayer Aktiengesellsch...

2026-03-04 09:35:44 ET Health Care ETFs: ( XLV ), ( VHT ), ( IHI ), ( IXJ ), ( IYH ), ( FHLC ), ( XPH ), ( PPH ...

/C O R R E C T I O N -- Johnson & Johnson/ /C O R R E C T I O N -- Johnson & Johnson/ PR Newswire In the news release, Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE), issued 03-Mar-2026 by Johnson &am...

2026-03-03 14:22:07 ET Read the full article on Seeking Alpha For further details see: FNDB: A Balanced Core ETF With A Value Tilt

2026-03-03 14:02:16 ET Johnson & Johnson (JNJ) TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM EST... Read the full article on Seeking Alpha For further details see: Johnson & Johnson (JNJ) Presents at TD Cowen 46th Annual Health Care Conference Tr...

2026-03-03 13:18:00 ET The following segment was excerpted from the Wasatch Global Value Fund Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Wasatch Global Value Fund Q4 2025 Performance Review

Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE) Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE) PR Newswire Fast Track designation refle...

Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 14 th to review first-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Da...

2026-03-02 15:43:49 ET More on ConocoPhillips, Loar Holdings, etc. Loar Holdings Inc. (LOAR) Q4 2025 Earnings Call Transcript Loar Holdings Inc. 2025 Q4 - Results - Earnings Call Presentation Valero Energy: Still Pumping Cash, But The Valuation Looks Bloated ...